Comparative studies of suppression of malignant cancer cell phenotype by antisense oligo DNA and small interfering RNA

N. Hiroi, Akira Funahashi, H. Kitano

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

One of the distinguishing features of malignant tumor cells is the ability to proliferate in an anchorage-independent manner; methods that effectively suppress this phenotype may be applicable to the therapeutic inhibition of the malignancy of cancers. Interfering RNA is a potentially powerful tool for cancer therapy because of its specificity of target selection and remarkably high efficiency in target mRNA suppression. We studied the use of two knockdown strategies, antisense oligo DNA (AS-ODN) and small interfering RNA (siRNA), and showed how the anchorage-independent proliferation of malignant cells could be blocked efficiently. Anchorage-independent proliferation of rat fibroblasts transformed with v-src was suppressed with only a single 1-μM dose of AS-ODN; similar suppression using siRNA required treatment with 1 nM siRNA every 12 h. With our experimental system, the molecular stability of AS-ODN allowed the use of a simple treatment regimen to control the amount of the target molecule, providing that the treatment dose was sufficiently high. In comparison, siRNA treatment was effective at lower doses, but more frequent treatment was necessary to achieve the same suppression of proliferation.

Original languageEnglish
Pages (from-to)7-12
Number of pages6
JournalCancer Gene Therapy
Volume13
Issue number1
DOIs
Publication statusPublished - 2006 Jan

Fingerprint

Antisense DNA
Small Interfering RNA
Phenotype
Neoplasms
Fibroblasts
Cell Proliferation
RNA
Messenger RNA
Therapeutics

Keywords

  • Anchorage-independent growth
  • Antisense oligo DNA
  • Small interfering RNA

ASJC Scopus subject areas

  • Cancer Research
  • Genetics

Cite this

Comparative studies of suppression of malignant cancer cell phenotype by antisense oligo DNA and small interfering RNA. / Hiroi, N.; Funahashi, Akira; Kitano, H.

In: Cancer Gene Therapy, Vol. 13, No. 1, 01.2006, p. 7-12.

Research output: Contribution to journalArticle

@article{674b8f81c3b844f88ca3fecb92662901,
title = "Comparative studies of suppression of malignant cancer cell phenotype by antisense oligo DNA and small interfering RNA",
abstract = "One of the distinguishing features of malignant tumor cells is the ability to proliferate in an anchorage-independent manner; methods that effectively suppress this phenotype may be applicable to the therapeutic inhibition of the malignancy of cancers. Interfering RNA is a potentially powerful tool for cancer therapy because of its specificity of target selection and remarkably high efficiency in target mRNA suppression. We studied the use of two knockdown strategies, antisense oligo DNA (AS-ODN) and small interfering RNA (siRNA), and showed how the anchorage-independent proliferation of malignant cells could be blocked efficiently. Anchorage-independent proliferation of rat fibroblasts transformed with v-src was suppressed with only a single 1-μM dose of AS-ODN; similar suppression using siRNA required treatment with 1 nM siRNA every 12 h. With our experimental system, the molecular stability of AS-ODN allowed the use of a simple treatment regimen to control the amount of the target molecule, providing that the treatment dose was sufficiently high. In comparison, siRNA treatment was effective at lower doses, but more frequent treatment was necessary to achieve the same suppression of proliferation.",
keywords = "Anchorage-independent growth, Antisense oligo DNA, Small interfering RNA",
author = "N. Hiroi and Akira Funahashi and H. Kitano",
year = "2006",
month = "1",
doi = "10.1038/sj.cgt.7700869",
language = "English",
volume = "13",
pages = "7--12",
journal = "Cancer Gene Therapy",
issn = "0929-1903",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - Comparative studies of suppression of malignant cancer cell phenotype by antisense oligo DNA and small interfering RNA

AU - Hiroi, N.

AU - Funahashi, Akira

AU - Kitano, H.

PY - 2006/1

Y1 - 2006/1

N2 - One of the distinguishing features of malignant tumor cells is the ability to proliferate in an anchorage-independent manner; methods that effectively suppress this phenotype may be applicable to the therapeutic inhibition of the malignancy of cancers. Interfering RNA is a potentially powerful tool for cancer therapy because of its specificity of target selection and remarkably high efficiency in target mRNA suppression. We studied the use of two knockdown strategies, antisense oligo DNA (AS-ODN) and small interfering RNA (siRNA), and showed how the anchorage-independent proliferation of malignant cells could be blocked efficiently. Anchorage-independent proliferation of rat fibroblasts transformed with v-src was suppressed with only a single 1-μM dose of AS-ODN; similar suppression using siRNA required treatment with 1 nM siRNA every 12 h. With our experimental system, the molecular stability of AS-ODN allowed the use of a simple treatment regimen to control the amount of the target molecule, providing that the treatment dose was sufficiently high. In comparison, siRNA treatment was effective at lower doses, but more frequent treatment was necessary to achieve the same suppression of proliferation.

AB - One of the distinguishing features of malignant tumor cells is the ability to proliferate in an anchorage-independent manner; methods that effectively suppress this phenotype may be applicable to the therapeutic inhibition of the malignancy of cancers. Interfering RNA is a potentially powerful tool for cancer therapy because of its specificity of target selection and remarkably high efficiency in target mRNA suppression. We studied the use of two knockdown strategies, antisense oligo DNA (AS-ODN) and small interfering RNA (siRNA), and showed how the anchorage-independent proliferation of malignant cells could be blocked efficiently. Anchorage-independent proliferation of rat fibroblasts transformed with v-src was suppressed with only a single 1-μM dose of AS-ODN; similar suppression using siRNA required treatment with 1 nM siRNA every 12 h. With our experimental system, the molecular stability of AS-ODN allowed the use of a simple treatment regimen to control the amount of the target molecule, providing that the treatment dose was sufficiently high. In comparison, siRNA treatment was effective at lower doses, but more frequent treatment was necessary to achieve the same suppression of proliferation.

KW - Anchorage-independent growth

KW - Antisense oligo DNA

KW - Small interfering RNA

UR - http://www.scopus.com/inward/record.url?scp=29144503049&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=29144503049&partnerID=8YFLogxK

U2 - 10.1038/sj.cgt.7700869

DO - 10.1038/sj.cgt.7700869

M3 - Article

C2 - 16082382

AN - SCOPUS:29144503049

VL - 13

SP - 7

EP - 12

JO - Cancer Gene Therapy

JF - Cancer Gene Therapy

SN - 0929-1903

IS - 1

ER -